United Asset Strategies’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86M | Sell |
4,187
-425
| -9% | -$189K | 0.16% | 105 |
|
|
2025
Q1 | $2.24M | Buy |
4,612
+661
| +17% | +$320K | 0.21% | 91 |
|
|
2024
Q4 | $1.59M | Buy |
3,951
+196
| +5% | +$78.9K | 0.15% | 116 |
|
|
2024
Q3 | $1.75M | Buy |
3,755
+82
| +2% | +$38.1K | 0.16% | 114 |
|
|
2024
Q2 | $1.72M | Buy |
3,673
+2,203
| +150% | +$1.03M | 0.17% | 108 |
|
|
2024
Q1 | $614K | Buy |
+1,470
| New | +$614K | 0.06% | 182 |
|